Strategic Global Advisors, LLC Neurocrine Biosciences Inc Transaction History
Strategic Global Advisors, LLC
- $502 Million
- Q3 2024
A detailed history of Strategic Global Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 19,694 shares of NBIX stock, worth $2.52 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
19,694
Previous 19,882
0.95%
Holding current value
$2.52 Million
Previous $2.74 Million
17.17%
% of portfolio
0.45%
Previous 0.59%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
627Shares Held
94.3MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.82 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.28 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$659 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$329 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$238 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...